Inhibition of major virulence pathways of Streptococcus mutans by quercitrin and deoxynojirimycin: a synergistic approach of infection control

PLoS One. 2014 Mar 12;9(3):e91736. doi: 10.1371/journal.pone.0091736. eCollection 2014.

Abstract

Objectives: To evaluate the synergistic effect of Quercitrin and Deoxynojirimycin (DNJ) together with their individual inhibitory effect against virulence pathways of Streptococcus mutans.

Methodology: MICs of both the compounds were determined by the microdilution method, followed by their in vitrosynergy using checkerboard and time kill assay. The nature of interaction was classified as synergistic on the basis of fractional inhibitory concentration index (FICI) value of ≤0.5. Furthermore, the activity of Quercitrin and DNJ was evaluated individually and in combination against various cariogenic properties of S. mutans UA159 such as acidogenesis, aciduracity, glucan production, hydrophobicity, biofilm and adherence. Moreover, expression of virulent genes in S. mutans was analysed by quantitative RT- PCR (qRT-PCR) and inhibition of F1F0-ATPase, lactate dehydrogenase and enolase was also evaluated. Finally, scanning electron microscopy (SEM) was used to investigate structural obliteration of biofilm.

Results: The in vitro synergism between Quercitrin and DNJ was observed, with a FICI of 0.313. Their MIC values were found to be 64 μg/ml and 16 μg/ml respectively. The synergistic combination consistently showed best activity against all the virulence factors as compared to Quercitrin and DNJ individually. A reduction in glucan synthesis and biofilm formation was observed at different phases of growth. The qRT-PCR revealed significant downregulation of various virulent genes. Electron micrographs depicted the obliteration of biofilm as compared to control and the activity of cariogenic enzymes was also inhibited.

Conclusions: The whole study reflects a prospective role of Quercitrin and DNJ in combination as a potent anticariogenic agent against S. mutans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Deoxynojirimycin / pharmacology
  • Anti-Bacterial Agents / pharmacology*
  • Antigens, Bacterial / metabolism
  • Bacterial Adhesion / drug effects
  • Biofilms / drug effects
  • Biofilms / growth & development
  • Drug Synergism
  • Extracellular Space / drug effects
  • Extracellular Space / metabolism
  • Gene Expression Regulation, Bacterial / drug effects
  • Glucans / metabolism
  • Glucosamine / analogs & derivatives*
  • Glucosamine / pharmacology
  • Hydrophobic and Hydrophilic Interactions
  • Infection Control
  • Microbial Sensitivity Tests
  • Microbial Viability / drug effects
  • Polysaccharides, Bacterial / metabolism
  • Quercetin / analogs & derivatives*
  • Quercetin / pharmacology
  • Streptococcus mutans / drug effects*
  • Streptococcus mutans / growth & development
  • Streptococcus mutans / metabolism
  • Streptococcus mutans / pathogenicity*
  • Stress, Physiological / drug effects
  • Virulence / drug effects

Substances

  • Anti-Bacterial Agents
  • Antigens, Bacterial
  • Glucans
  • Polysaccharides, Bacterial
  • deoxynojirimycine
  • 1-Deoxynojirimycin
  • quercitrin
  • Quercetin
  • Glucosamine

Grants and funding

This study was supported by internal funds of Interdisciplinary Biotechnology Unit, Aligarh Muslim University and Indian Councel of Medical Research grant no. 59/6/2009/BMS/TRM to AUK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.